Enzo Biochem (ENZ) Reports In-Line Q1 Loss

Enzo Biochem (NYSE: ENZ) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $25 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
• Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook